$MVST
Microvast Holdings, Inc.

2023 Q4 Form 10-Q Financial Statement

#000176068923000040 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $104.6M $80.12M
YoY Change 61.39% 107.47%
Cost Of Revenue $81.55M $62.23M
YoY Change 30.33% 69.93%
Gross Profit $23.02M $17.88M
YoY Change 934.32% 797.34%
Gross Profit Margin 22.02% 22.32%
Selling, General & Admin $34.64M $31.43M
YoY Change 29.29% 11.68%
% of Gross Profit 150.46% 175.76%
Research & Development $11.40M $13.24M
YoY Change 8.54% 15.57%
% of Gross Profit 49.49% 74.04%
Depreciation & Amortization $7.620M $5.036M
YoY Change 59.28% 2.34%
% of Gross Profit 33.1% 28.16%
Operating Expenses $46.04M $44.67M
YoY Change 23.45% 12.8%
Operating Profit -$23.01M -$26.35M
YoY Change -34.37% -28.96%
Interest Expense -$1.063M $491.0K
YoY Change -237.16% -36.56%
% of Operating Profit
Other Income/Expense, Net -$1.302M $127.0K
YoY Change -800.0% -63.61%
Pretax Income -$24.58M -$26.17M
YoY Change -26.98% -28.38%
Income Tax $10.00K $0.00
% Of Pretax Income
Net Earnings -$24.54M -$26.13M
YoY Change -27.19% -28.5%
Net Earnings / Revenue -23.46% -32.62%
Basic Earnings Per Share -$0.08
Diluted Earnings Per Share -$0.08 -$0.08
COMMON SHARES
Basic Shares Outstanding 316.5M shares 316.3M shares
Diluted Shares Outstanding 313.1M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.18M $92.89M
YoY Change -80.44% -68.6%
Cash & Equivalents $44.54M $67.40M
Short-Term Investments $5.634M $25.50M
Other Short-Term Assets $63.23M $47.64M
YoY Change -21.07% -53.4%
Inventory $149.7M $126.9M
Prepaid Expenses
Receivables $138.7M $116.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $425.6M $403.9M
YoY Change -21.92% -28.83%
LONG-TERM ASSETS
Property, Plant & Equipment $620.7M $549.5M
YoY Change 85.2% 91.92%
Goodwill
YoY Change
Intangibles $3.136M $3.210M
YoY Change 91.69% 89.27%
Long-Term Investments
YoY Change
Other Assets $9.661M $28.54M
YoY Change -86.88% -45.96%
Total Long-Term Assets $671.1M $612.7M
YoY Change 52.57% 51.12%
TOTAL ASSETS
Total Short-Term Assets $425.6M $403.9M
Total Long-Term Assets $671.1M $612.7M
Total Assets $1.097B $1.017B
YoY Change 11.35% 4.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $112.6M $95.29M
YoY Change 150.35% 164.91%
Accrued Expenses $30.51M $10.22M
YoY Change 34.78% -87.15%
Deferred Revenue $43.09M $54.48M
YoY Change -20.51% 726.86%
Short-Term Debt $35.39M $24.82M
YoY Change 103.43% 253.08%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $403.4M $336.4M
YoY Change 59.82% 45.1%
LONG-TERM LIABILITIES
Long-Term Debt $86.92M $74.73M
YoY Change 19.25% -8.7%
Other Long-Term Liabilities $24.86M $20.82M
YoY Change -22.51% -29.59%
Total Long-Term Liabilities $24.86M $20.82M
YoY Change -22.51% -29.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $403.4M $336.4M
Total Long-Term Liabilities $24.86M $20.82M
Total Liabilities $532.5M $449.2M
YoY Change 43.16% 25.81%
SHAREHOLDERS EQUITY
Retained Earnings -$897.5M -$873.0M
YoY Change 13.44% 15.25%
Common Stock $32.00K $32.00K
YoY Change 3.23% 3.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $564.2M $565.3M
YoY Change
Total Liabilities & Shareholders Equity $1.097B $1.017B
YoY Change 11.35% 4.48%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$24.54M -$26.13M
YoY Change -27.19% -28.5%
Depreciation, Depletion And Amortization $7.620M $5.036M
YoY Change 59.28% 2.34%
Cash From Operating Activities -$4.953M -$29.34M
YoY Change -206.13% -693.93%
INVESTING ACTIVITIES
Capital Expenditures $33.21M $59.94M
YoY Change -49.8% -456.66%
Acquisitions
YoY Change
Other Investing Activities $20.73M $224.0K
YoY Change -182.69% 22300.0%
Cash From Investing Activities -$12.48M -$59.72M
YoY Change -86.31% 255.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.89M 6.863M
YoY Change -171.39% -81.98%
NET CHANGE
Cash From Operating Activities -4.953M -29.34M
Cash From Investing Activities -12.48M -59.72M
Cash From Financing Activities 20.89M 6.863M
Net Change In Cash 3.450M -82.20M
YoY Change -102.98% -413.42%
FREE CASH FLOW
Cash From Operating Activities -$4.953M -$29.34M
Capital Expenditures $33.21M $59.94M
Free Cash Flow -$38.17M -$89.28M
YoY Change -37.93% -510.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
39603000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15985000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84719000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
565347000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
0 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
1991000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
44674000 usd
us-gaap Operating Expenses
OperatingExpenses
133400000 usd
us-gaap Operating Expenses
OperatingExpenses
119872000 usd
CY2022Q3 mvst Subsidy Income
SubsidyIncome
520000 usd
CY2023Q3 mvst Subsidy Income
SubsidyIncome
442000 usd
mvst Subsidy Income
SubsidyIncome
1233000 usd
mvst Subsidy Income
SubsidyIncome
1156000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-37090000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-26348000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-125320000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-84513000 usd
CY2022Q3 mvst Interest Income
InterestIncome
870000 usd
CY2023Q3 mvst Interest Income
InterestIncome
582000 usd
mvst Interest Income
InterestIncome
1604000 usd
mvst Interest Income
InterestIncome
3481000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
774000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
491000 usd
us-gaap Interest Expense
InterestExpense
2465000 usd
us-gaap Interest Expense
InterestExpense
1437000 usd
CY2023Q3 mvst Gain On Change In Fair Value Of Warrant Liability
GainOnChangeInFairValueOfWarrantLiability
-42000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
758000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
673000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36544000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26172000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-124502000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-81821000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Profit Loss
ProfitLoss
-81821000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-42000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-21000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-36544000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-26130000 usd
us-gaap Net Income Loss
NetIncomeLoss
-124502000 usd
us-gaap Net Income Loss
NetIncomeLoss
-81800000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
309541499 shares
us-gaap Profit Loss
ProfitLoss
-124502000 usd
us-gaap Profit Loss
ProfitLoss
-81821000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2192000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-37612000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-18006000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-57546000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-28364000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-162114000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-99827000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-183000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28310000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-162114000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
567338000 usd
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
612977000 usd
CY2022Q3 mvst Gain On Change In Fair Value Of Warrant Liability
GainOnChangeInFairValueOfWarrantLiability
101000 usd
mvst Gain On Change In Fair Value Of Warrant Liability
GainOnChangeInFairValueOfWarrantLiability
921000 usd
mvst Gain On Change In Fair Value Of Warrant Liability
GainOnChangeInFairValueOfWarrantLiability
-25000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
349000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
127000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-36544000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-26172000 usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
305977372 shares
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-54000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57546000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-99644000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-26172000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-2192000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
612977000 usd
us-gaap Profit Loss
ProfitLoss
-81821000 usd
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2174000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52014000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-18006000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
567338000 usd
us-gaap Profit Loss
ProfitLoss
-124502000 usd
us-gaap Profit Loss
ProfitLoss
-81821000 usd
mvst Gain Loss On Disposal Of Property Plant And Equipment
GainLossOnDisposalOfPropertyPlantAndEquipment
11000 usd
mvst Gain Loss On Disposal Of Property Plant And Equipment
GainLossOnDisposalOfPropertyPlantAndEquipment
832000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
15161000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
14643000 usd
mvst Amortization Of Land Use Right And Intangible Assets
AmortizationOfLandUseRightAndIntangibleAssets
420000 usd
mvst Amortization Of Land Use Right And Intangible Assets
AmortizationOfLandUseRightAndIntangibleAssets
593000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1662000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2108000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
72925000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
51641000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-921000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
25000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
337000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1038000 usd
mvst Provision For Obsolete Inventories
ProvisionForObsoleteInventories
3148000 usd
mvst Provision For Obsolete Inventories
ProvisionForObsoleteInventories
928000 usd
mvst Impairment Loss From Property Plant And Equipment
ImpairmentLossFromPropertyPlantAndEquipment
1546000 usd
mvst Impairment Loss From Property Plant And Equipment
ImpairmentLossFromPropertyPlantAndEquipment
473000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
8263000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
9017000 usd
us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
-1386000 usd
us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
22372000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5024000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
911000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39517000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
54473000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3764000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12666000 usd
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
0 usd
mvst Increase Decrease In Notes Payable
IncreaseDecreaseInNotesPayable
19942000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-529000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
53400000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
5608000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
515000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-12203000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1374000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
15389000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2760000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1050000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-319000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-58595000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70350000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
84722000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153574000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
425000 usd
mvst Proceeds On Disposal Of Property Plant And Equipment
ProceedsOnDisposalOfPropertyPlantAndEquipment
3000 usd
mvst Proceeds On Disposal Of Property Plant And Equipment
ProceedsOnDisposalOfPropertyPlantAndEquipment
879000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-153120000 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
58708000 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
18439000 usd
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
24482000 usd
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
6286000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34226000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11322000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-120410000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
536109000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295816000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
119883000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
415699000 usd
CY2022Q3 mvst Payable For Purchase Of Property Plant And Equipment
PayableForPurchaseOfPropertyPlantAndEquipment
38044000 usd
CY2023Q3 mvst Payable For Purchase Of Property Plant And Equipment
PayableForPurchaseOfPropertyPlantAndEquipment
75781000 usd
us-gaap Nature Of Operations
NatureOfOperations
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microvast, Inc. was incorporated under the laws of the State of Texas in the United States of America on October 12, 2006 and re-domiciled to the State of Delaware on December 31, 2015. On July 23, 2021 (the “Closing Date”), Microvast, Inc. and Tuscan Holdings Corp.(“Tuscan”) consummated the previously announced merger (the “Merger” or the "Business Combination"), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) dated February 1, 2021, between Tuscan, Microvast, Inc. and TSCN Merger Sub Inc., a Delaware corporation (“Merger Sub”).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Merger Agreement, the Merger Sub merged with and into Microvast, Inc., with Microvast, Inc. surviving the Merger. As a result of the Merger, Tuscan was renamed “Microvast Holdings, Inc.” (the “Company”). The Merger was accounted for as a reverse recapitalization as Microvast, Inc. was determined to be the accounting acquirer under Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company and its subsidiaries (collectively, the “Group”) are primarily engaged in developing, manufacturing, and selling electronic power products for electric vehicles and energy storage across the globe.</span></div>
CY2023Q3 mvst Working Capital
WorkingCapital
67520000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
567338000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-872965000 usd
us-gaap Profit Loss
ProfitLoss
-81821000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70350000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-158200000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53928000 usd
CY2023Q3 mvst Product Backlog Amount
ProductBacklogAmount
678681000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38616000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80116000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139698000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
202042000 usd
CY2022Q3 mvst Revenue Related To Contracts Balance
RevenueRelatedToContractsBalance
722000 usd
CY2023Q3 mvst Revenue Related To Contracts Balance
RevenueRelatedToContractsBalance
1191000 usd
mvst Revenue Related To Contracts Balance
RevenueRelatedToContractsBalance
550000 usd
mvst Revenue Related To Contracts Balance
RevenueRelatedToContractsBalance
2485000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19612000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
19366000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2415000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-20000 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-607000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
123711000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
119542000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4407000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3242000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
119304000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
116300000 usd
CY2022Q2 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
5828000 usd
CY2023Q2 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
3468000 usd
CY2021Q4 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
5005000 usd
CY2022Q4 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
4407000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-43000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-206000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
337000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1038000 usd
CY2022Q3 mvst Accounts Receivable Write Off
AccountsReceivableWriteOff
12000 usd
CY2023Q3 mvst Accounts Receivable Write Off
AccountsReceivableWriteOff
0 usd
mvst Accounts Receivable Write Off
AccountsReceivableWriteOff
165000 usd
mvst Accounts Receivable Write Off
AccountsReceivableWriteOff
66000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
121000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-337000 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-182000 usd
CY2022Q3 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
5436000 usd
CY2023Q3 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
3242000 usd
CY2022Q3 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
5436000 usd
CY2023Q3 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
3242000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
48747000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
78215000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29331000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32969000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6174000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15729000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
84252000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
126913000 usd
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
1229000 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
3148000 usd
us-gaap Inventory Write Down
InventoryWriteDown
928000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3493000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5405000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1857000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2195000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1636000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3210000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
61000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
122000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
183000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
371000 usd
CY2023Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
121000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
481000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
477000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
476000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
469000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
381000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
805000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3210000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
13044000 usd
CY2023Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
15176000 usd
CY2022Q4 mvst Payables For Purchase Of Property Plant And Equipment
PayablesForPurchaseOfPropertyPlantAndEquipment
29183000 usd
CY2023Q3 mvst Payables For Purchase Of Property Plant And Equipment
PayablesForPurchaseOfPropertyPlantAndEquipment
75781000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8608000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13934000 usd
CY2022Q4 mvst Accrued Payroll And Welfare
AccruedPayrollAndWelfare
4716000 usd
CY2023Q3 mvst Accrued Payroll And Welfare
AccruedPayrollAndWelfare
4315000 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2641000 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2363000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
298000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1129000 usd
CY2023Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
15176000 usd
CY2022Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
29016000 usd
CY2023Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
18172000 usd
CY2022Q4 mvst Product Warranty Total
ProductWarrantyTotal
42060000 usd
CY2023Q3 mvst Product Warranty Total
ProductWarrantyTotal
33348000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
6296000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
6703000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1934000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2415000 usd
CY2022Q4 mvst Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
66720000 usd
CY2023Q3 mvst Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
121816000 usd
CY2022Q2 mvst Movement Of Product Warranty Opening Balance
MovementOfProductWarrantyOpeningBalance
43703000 usd
CY2023Q2 mvst Movement Of Product Warranty Opening Balance
MovementOfProductWarrantyOpeningBalance
37108000 usd
CY2021Q4 mvst Movement Of Product Warranty Opening Balance
MovementOfProductWarrantyOpeningBalance
58458000 usd
CY2022Q4 mvst Movement Of Product Warranty Opening Balance
MovementOfProductWarrantyOpeningBalance
42060000 usd
CY2022Q3 mvst Warranty Expense Provided During The Period
WarrantyExpenseProvidedDuringThePeriod
2028000 usd
CY2023Q3 mvst Warranty Expense Provided During The Period
WarrantyExpenseProvidedDuringThePeriod
3567000 usd
mvst Warranty Expense Provided During The Period
WarrantyExpenseProvidedDuringThePeriod
8263000 usd
mvst Warranty Expense Provided During The Period
WarrantyExpenseProvidedDuringThePeriod
9017000 usd
CY2022Q3 mvst Utilization Of The Product Warranty During The Period
UtilizationOfTheProductWarrantyDuringThePeriod
4357000 usd
CY2023Q3 mvst Utilization Of The Product Warranty During The Period
UtilizationOfTheProductWarrantyDuringThePeriod
7125000 usd
mvst Utilization Of The Product Warranty During The Period
UtilizationOfTheProductWarrantyDuringThePeriod
22957000 usd
mvst Utilization Of The Product Warranty During The Period
UtilizationOfTheProductWarrantyDuringThePeriod
15635000 usd
CY2022Q3 mvst Warranty Expense Exchange Difference During The Period
WarrantyExpenseExchangeDifferenceDuringThePeriod
-2467000 usd
CY2023Q3 mvst Warranty Expense Exchange Difference During The Period
WarrantyExpenseExchangeDifferenceDuringThePeriod
-202000 usd
mvst Warranty Expense Exchange Difference During The Period
WarrantyExpenseExchangeDifferenceDuringThePeriod
-4857000 usd
mvst Warranty Expense Exchange Difference During The Period
WarrantyExpenseExchangeDifferenceDuringThePeriod
-2094000 usd
CY2022Q3 mvst Movement Of Product Warranty Ending Balance
MovementOfProductWarrantyEndingBalance
38907000 usd
CY2023Q3 mvst Movement Of Product Warranty Ending Balance
MovementOfProductWarrantyEndingBalance
33348000 usd
CY2022Q3 mvst Movement Of Product Warranty Ending Balance
MovementOfProductWarrantyEndingBalance
38907000 usd
CY2023Q3 mvst Movement Of Product Warranty Ending Balance
MovementOfProductWarrantyEndingBalance
33348000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
13044000 usd
CY2022Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
CY2023Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
475000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
CY2022Q2 mvst Bank Borrowings Beginning Balance
BankBorrowingsBeginningBalance
8807000 usd
CY2023Q2 mvst Bank Borrowings Beginning Balance
BankBorrowingsBeginningBalance
49146000 usd
CY2021Q4 mvst Bank Borrowings Beginning Balance
BankBorrowingsBeginningBalance
13301000 usd
CY2022Q4 mvst Bank Borrowings Beginning Balance
BankBorrowingsBeginningBalance
46395000 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
45242000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
9207000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
58708000 usd
CY2022Q3 mvst Repayments Of Principal
RepaymentsOfPrincipal
7150000 usd
CY2023Q3 mvst Repayments Of Principal
RepaymentsOfPrincipal
2347000 usd
mvst Repayments Of Principal
RepaymentsOfPrincipal
24482000 usd
CY2022Q3 mvst Exchange Difference
ExchangeDifference
-1914000 usd
CY2023Q3 mvst Exchange Difference
ExchangeDifference
-349000 usd
mvst Exchange Difference
ExchangeDifference
-2542000 usd
CY2022Q3 mvst Bank Borrowings Ending Balance
BankBorrowingsEndingBalance
44985000 usd
CY2023Q3 mvst Bank Borrowings Ending Balance
BankBorrowingsEndingBalance
55657000 usd
CY2022Q3 mvst Bank Borrowings Ending Balance
BankBorrowingsEndingBalance
44985000 usd
CY2023Q3 mvst Bank Borrowings Ending Balance
BankBorrowingsEndingBalance
55657000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
17398000 usd
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
24818000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
28997000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
30839000 usd
mvst Debt Instrument Convertible Amount Subsidiary Value Threshold
DebtInstrumentConvertibleAmountSubsidiaryValueThreshold
950000000 usd
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
14629000 usd
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
100000000 cny
CY2022Q4 mvst Pledged Buildings
PledgedBuildings
27245000 usd
CY2023Q3 mvst Pledged Buildings
PledgedBuildings
24523000 usd
CY2022Q4 mvst Pledged Land Use Rights
PledgedLandUseRights
12639000 usd
CY2023Q3 mvst Pledged Land Use Rights
PledgedLandUseRights
11734000 usd
CY2022Q4 mvst Pledged Total Asset
PledgedTotalAsset
39884000 usd
CY2023Q3 mvst Pledged Total Asset
PledgedTotalAsset
36257000 usd
CY2022Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
29016000 usd
CY2023Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
18172000 usd
CY2022Q4 mvst Deferred Subsidy Income Noncurrent
DeferredSubsidyIncomeNoncurrent
3066000 usd
CY2023Q3 mvst Deferred Subsidy Income Noncurrent
DeferredSubsidyIncomeNoncurrent
2645000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32082000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20817000 usd
CY2022Q4 mvst Long Term Bonds Payable
LongTermBondsPayable
43888000 usd
CY2023Q3 mvst Long Term Bonds Payable
LongTermBondsPayable
43888000 usd
CY2018Q4 mvst Bond Loan
BondLoan
87776000 usd
CY2018Q4 mvst Bond Loan
BondLoan
600000000 cny
CY2018Q4 mvst Equity Holding Pledged Percentage
EquityHoldingPledgedPercentage
0.1239
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
14630000 usd
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
100000000 cny
CY2023Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.12
CY2023Q3 mvst Debt Instrument Of Subscribed Amount
DebtInstrumentOfSubscribedAmount
43888000 usd
CY2023Q3 mvst Debt Instrument Of Subscribed Amount
DebtInstrumentOfSubscribedAmount
300000000 cny
CY2021Q3 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
27600000 shares
CY2021Q3 mvst Class Of Warrant Or Right Exercisable Period
ClassOfWarrantOrRightExercisablePeriod
P30D
CY2021Q3 mvst Warrant Term
WarrantTerm
P5Y
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
231420000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
71197000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
302617000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
126000 usd
CY2022Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
126000 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
67398000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
21814000 usd
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
89212000 usd
CY2023Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
151000 usd
CY2023Q3 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
151000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1105000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
126000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
921000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-25000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
184000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
151000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
861000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2810000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
90000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
269000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y2M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
us-gaap Operating Lease Payments
OperatingLeasePayments
2822000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5726000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
828000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3220000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2744000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2495000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2365000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1788000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
11308000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24748000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5382000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
19366000 usd
CY2021Q3 us-gaap Standby Bond Purchase Commitment Expiration Period
StandbyBondPurchaseCommitmentExpirationPeriod
P10Y
CY2021Q3 mvst Exchange Ratio
ExchangeRatio
160.3
CY2021Q3 mvst Common Stock Reserved For Esop Plan
CommonStockReservedForESOPPlan
0.05
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
33503657 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.19
CY2021Q4 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding
4.95
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2900000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
227092 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.28
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
4.86
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36176565 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.08
CY2022Q3 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding
4.80
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
36176565 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.08
CY2022Q3 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Expected To Vest And Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueExpectedToVestAndExercisable
4.80
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11875830 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.20
CY2022Q3 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
5.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y2M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36091071 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.08
CY2022Q4 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding
4.80
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
640000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.18
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
895706 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
3.64
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
35835365 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.03
CY2023Q3 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding
4.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
35835365 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.03
CY2023Q3 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Expected To Vest And Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueExpectedToVestAndExercisable
4.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
23916879 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.14
CY2023Q3 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
4.90
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
43349000 usd
us-gaap Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1
NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1
P0Y10M24D
CY2023Q3 mvst Aggregate Intrinsic Value Of The Share Options
AggregateIntrinsicValueOfTheShareOptions
59000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4132000 usd
CY2022Q3 mvst Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-36544000 usd
CY2023Q3 mvst Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-26130000 usd
mvst Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-124502000 usd
mvst Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-81800000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
305977372 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
305977372 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
313108457 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
313108457 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301821464 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
301821464 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
309541499 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309541499 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2022Q3 mvst Shares Issuable Upon Exercise Of Share Options
SharesIssuableUponExerciseOfShareOptions
27032668 shares
CY2023Q3 mvst Shares Issuable Upon Exercise Of Share Options
SharesIssuableUponExerciseOfShareOptions
35830564 shares
mvst Shares Issuable Upon Exercise Of Share Options
SharesIssuableUponExerciseOfShareOptions
31529919 shares
mvst Shares Issuable Upon Exercise Of Share Options
SharesIssuableUponExerciseOfShareOptions
36001774 shares
CY2022Q3 mvst Shares Issuable Upon Vesting Of Non Vested Shares
SharesIssuableUponVestingOfNonVestedShares
1815043 shares
CY2023Q3 mvst Shares Issuable Upon Vesting Of Non Vested Shares
SharesIssuableUponVestingOfNonVestedShares
3898963 shares
mvst Shares Issuable Upon Vesting Of Non Vested Shares
SharesIssuableUponVestingOfNonVestedShares
1282482 shares
mvst Shares Issuable Upon Vesting Of Non Vested Shares
SharesIssuableUponVestingOfNonVestedShares
3652642 shares
CY2022Q3 mvst Shares Issuable Upon Exercise Of Capped Non Vested Shares
SharesIssuableUponExerciseOfCappedNonVestedShares
15017783 shares
CY2023Q3 mvst Shares Issuable Upon Exercise Of Capped Non Vested Shares
SharesIssuableUponExerciseOfCappedNonVestedShares
8343220 shares
mvst Shares Issuable Upon Exercise Of Capped Non Vested Shares
SharesIssuableUponExerciseOfCappedNonVestedShares
5280978 shares
mvst Shares Issuable Upon Exercise Of Capped Non Vested Shares
SharesIssuableUponExerciseOfCappedNonVestedShares
11662166 shares
CY2022Q3 mvst Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
28437000 shares
CY2023Q3 mvst Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
28437000 shares
mvst Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
28437000 shares
mvst Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
28437000 shares
CY2022Q3 mvst Shares Issuable Upon Vesting Of Earnout Shares
SharesIssuableUponVestingOfEarnoutShares
19999988 shares
CY2023Q3 mvst Shares Issuable Upon Vesting Of Earnout Shares
SharesIssuableUponVestingOfEarnoutShares
19999988 shares
mvst Shares Issuable Upon Vesting Of Earnout Shares
SharesIssuableUponVestingOfEarnoutShares
19999988 shares
mvst Shares Issuable Upon Vesting Of Earnout Shares
SharesIssuableUponVestingOfEarnoutShares
19999988 shares
CY2022Q3 mvst Shares Issuable That May Be Subject To Cancellation In Dollars
SharesIssuableThatMayBeSubjectToCancellationInDollars
1687500 shares
CY2023Q3 mvst Shares Issuable That May Be Subject To Cancellation In Dollars
SharesIssuableThatMayBeSubjectToCancellationInDollars
1687500 shares
mvst Shares Issuable That May Be Subject To Cancellation In Dollars
SharesIssuableThatMayBeSubjectToCancellationInDollars
1687500 shares
mvst Shares Issuable That May Be Subject To Cancellation In Dollars
SharesIssuableThatMayBeSubjectToCancellationInDollars
1687500 shares
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
25496000 usd

Files In Submission

Name View Source Status
0001760689-23-000040-index-headers.html Edgar Link pending
0001760689-23-000040-index.html Edgar Link pending
0001760689-23-000040.txt Edgar Link pending
0001760689-23-000040-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
microvast-smithseparatio.htm Edgar Link pending
microvast-smithseparatio001.jpg Edgar Link pending
microvast-smithseparatio002.jpg Edgar Link pending
microvast-smithseparatio003.jpg Edgar Link pending
microvast-smithseparatio004.jpg Edgar Link pending
microvast-smithseparatio005.jpg Edgar Link pending
microvast-smithseparatio006.jpg Edgar Link pending
microvast-smithseparatio007.jpg Edgar Link pending
microvast-smithseparatio008.jpg Edgar Link pending
microvast-smithseparatio009.jpg Edgar Link pending
mvst-20230930.htm Edgar Link pending
mvst-20230930.xsd Edgar Link pending
mvst20230930-ex311.htm Edgar Link pending
mvst20230930-ex312.htm Edgar Link pending
mvst20230930-ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mvst-20230930_cal.xml Edgar Link unprocessable
mvst-20230930_def.xml Edgar Link unprocessable
mvst-20230930_htm.xml Edgar Link completed
mvst20230930-ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mvst-20230930_pre.xml Edgar Link unprocessable
mvst-20230930_lab.xml Edgar Link unprocessable